Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database

Clicks: 502
ID: 118477
1997
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #14 of 581 articles by views in pediatrics

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 581 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
These data raise further doubts about the clinical effectiveness of ribavirin in infants and children with risk factors for severe disease. Selection bias, with ribavirin used for sicker children, may have influenced outcome. Nevertheless the long durations of hospitalization, ICU, ventilation, and …
Reference Key
bj1997pediatricsdoes Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Law BJ;Wang EE;MacDonald N;McDonald J;Dobson S;Boucher F;Langley J;Robinson J;Mitchell I;Stephens D;;
Journal pediatrics
Year 1997
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9099772
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Infant Prospective Studies newborn regression analysis Clinical Trial Multicenter Study length of stay severity of illness index community-acquired infections / drug therapy hospitalization antiviral agents / therapeutic use* ribavirin / therapeutic use* respiratory syncytial virus infections / drug therapy* respiratory syncytial virus infections / mortality respiratory syncytial viruses* e e wang b j law premature d stephens pmid:9099772 doi:10.1542/peds.99.3.e7 bronchiolitis / drug therapy bronchiolitis / mortality bronchiolitis / therapy bronchiolitis / virology* diseases / drug therapy respiratory syncytial virus infections / classification

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.